Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients

Journal of the Medical Association of Thailand

Volumn 87, Issue 4, 2004, Pages 367-371

  Sorraritchingchai, Sirikul ^a   Thongprasert, Sumitra ^a   Charoentum, Chaiyuth ^a   Chewasakulyong, Busayamas ^a   Moonprakan, Suttirak ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Chemotherapy for elderly patients NSCLC; Non Small Cell Lung Cancer; Vinorelbine

Indexed keywords

NAVELBINE;

ADENOCARCINOMA; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; FEMALE; GRANULOCYTOPENIA; HUMAN; LARGE CELL CARCINOMA; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHLEBITIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROSPECTIVE STUDIES; SURVIVAL RATE; THAILAND; VINBLASTINE;

EID: 2942596545     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gridelli C, Perrone F, Monfardini S et al. Lung cancer in the elderly. Eur. J Cancer 1997; 33: 2313-4.
2. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
3. Monfardini S. What do we know about the variables influencing clinical decision-making in elderly cancer patients? Eur J Cancer 1996; 32: 12-4.
4. Gridelli C. Chemotherapy of non-small cell lung cancer in the elderly. Lung Cancer. 2002; 38 (3 Suppl): 67-70.
5. Depierre A, Lemarie E, Dabouis G, et al. A phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 1991; 14: 115-9.
6. Le Chevalier T, Brisgand D, Douillard J-Y, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-7.
7. Veronesi A, Crivellari D, Magri MD, et al. Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients. Eur J Cancer. 1996; 32A (10): 1809-11.
8. Julien S, Jacoulet P, Dubiez A, et al. Non-small cell lung cancer: A study of long-term survival after vinorelbine monotherapy. The Oncologist 2000; 5: 115-9.
9. Gridelli C. ELVIS trial: A phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist. 2001; 6 Suppl 1: 4-7.
10. Colleoni M, Gaion F, Nelli P, et al. Weekly vinorelbine in elderly patients with non-small cell lung cancer. Tumori 1994; 80: 448-52.
11. Tononi A, Panzini I, Oliviero G, et al. Vinorelbine chemotherapy in non-small cell lung cancer: Experience in elderly patients. J Chemother 1997; 9: 304-8.
12. Gridelli C, Perrone F, Gallo C, et al., Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study. Eur J Cancer 1997; 33: 392-7.
13. WHO. Handbook for reporting results of cancer treatment. Geneva: WHO, 1979; 48: 22-7.